Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.
Szabo AG, Thorsen J, Iversen KF, Levring MB, Preiss B, Helleberg C, Breinholt MF, Hermansen E, Gjerdrum LMR, Bønløkke ST, Nielsen K, Kjeldsen E, Teodorescu EM, Dokhi M, Kurt E, Strandholdt CN, Andersen MK, Vangsted AJ. Szabo AG, et al. Among authors: iversen kf. Am J Hematol. 2022 Mar 1;97(3):E117-E120. doi: 10.1002/ajh.26449. Epub 2021 Dec 29. Am J Hematol. 2022. PMID: 34967035 Free article. No abstract available.
Clinically-suspected cast nephropathy: A retrospective, national, real-world study.
Szabo AG, Thorsen J, Iversen KF, Hansen CT, Teodorescu EM, Pedersen SB, Flaeng SB, Strandholdt C, Frederiksen M, Vase MØ, Frølund UC, Krustrup D, Plesner T, Vangsted AJ. Szabo AG, et al. Among authors: iversen kf. Am J Hematol. 2020 Nov;95(11):1352-1360. doi: 10.1002/ajh.25959. Epub 2020 Aug 26. Am J Hematol. 2020. PMID: 32777108 Free article.
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
Højholt KL, Gregersen H, Szabo AG, Klausen TW, Levring MB, Preiss B, Helleberg C, Breinholt MF, Hermansen E, Rahbek Gjerdrum LM, Bønløkke ST, Nielsen K, Kjeldsen E, Iversen KF, Teodorescu EM, Kurt E, Strandholdt C, Andersen MK, Vangsted AJ. Højholt KL, et al. Among authors: iversen kf. Hematol Oncol. 2021 Oct;39(4):521-528. doi: 10.1002/hon.2906. Epub 2021 Aug 2. Hematol Oncol. 2021. PMID: 34342035
The real-world outcomes of multiple myeloma patients treated with daratumumab.
Szabo AG, Klausen TW, Levring MB, Preiss B, Helleberg C, Breinholt MF, Hermansen E, Gjerdrum LMR, Bønløkke ST, Nielsen K, Kjeldsen E, Iversen KF, Teodorescu EM, Dokhi M, Kurt E, Strandholdt C, Andersen MK, Vangsted AJ. Szabo AG, et al. Among authors: iversen kf. PLoS One. 2021 Oct 13;16(10):e0258487. doi: 10.1371/journal.pone.0258487. eCollection 2021. PLoS One. 2021. PMID: 34644367 Free PMC article.
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.
Harsløf M, Chanchiri I, Silkjær T, Frølund UC, Teodorescu EM, Nielsen KB, Nielsen PI, Pedersen PT, Iversen KF, Lund T, Grønbæk K, Thorsteinsdottir S, Vangsted A, Szabo AG. Harsløf M, et al. Among authors: iversen kf. EJHaem. 2024 Mar 27;5(2):316-324. doi: 10.1002/jha2.881. eCollection 2024 Apr. EJHaem. 2024. PMID: 38633122 Free PMC article.
13 results